Stroke is a global health concern and it is imperative that therapeutic strategies with wide treatment time frames be developed to improve neurological outcome in patients. Patients with diabetes mellitus who suffer a stroke have worse neurological outcomes and long-term ...
Read More »Creative Medical Technology Holdings Files Patent on AmnioStem Exosome Stroke Therapy
Creative Medical Technology Holdings (the “Company”) (OTCQB:CELZ) announced today filing of US patent application #62/400557 entitled “Treatment of Stroke by Amniotic Fluid Derived Stem Cell Conditioned Media and Products Derived Thereof.” The patent application covers the use of the Company’s ...
Read More »A miRNA panel in peripheral blood exosomes as novel biomarkers
Progression of asymptomatic carotid artery stenosis (ACAS) in patients with >50% luminal narrowing is considered a potential risk factor for ischemic stroke; however, subclinical molecular biomarkers of ACAS progression are lacking. Recent studies suggest a regulatory function for several microRNAs ...
Read More »Systemic administration of exosomes released from mesenchymal stromal cells promote functional recovery and neurovascular plasticity
Here, for the first time, researchers at the Henry Ford Hospital test a novel hypothesis that systemic treatment of stroke with exosomes derived from multipotent mesenchymal stromal cells (MSCs) promote neurovascular remodeling and functional recovery after stroke in rats. Adult ...
Read More »